Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT05573620
Brief Summary:
Investigation of Acceptance and Commitment Therapy (ACT) for the psychological treatment of public speaking fear. Two ACT-based treatment delivery modalities (in vivo exposure vs. virtual reality) were compared.
Detailed Description:
After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry.
The clinical trial will include a control group (waiting list).
Patients who meet eligibility requirements will be assigned to a waiting list, in vivo exposure and Virtual Reality.
Psychological intervention consisted in a 5-session individual face-to-face delivered ACT-based treatment.
The participants will be assessed through self-report instruments and observational measurements before and after treatment and at 3 months follow-up.
Study:
NCT05573620
Study Brief:
Protocol Section:
NCT05573620